Cargando…
非小细胞肺癌免疫治疗生物标志物研究进展
Lung cancer is one of the most prevalent malignancies with the highest morbidity and mortality rates worldwide. In recent years, with the development of immune-oncology research and several therapeutic antibodies have reach the clinic, many breakthroughs have been made in immunotherapy. The advent o...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796128/ https://www.ncbi.nlm.nih.gov/pubmed/35078285 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.55 |